Rixubis® (coagulation factor IX (recombinant))
for Hemophilia

Rixubis is a recombinant factor IX therapy used to prevent and control bleeding in individuals with hemophilia B. It replaces the missing clotting protein to support blood clot formation, reducing the risk of prolonged or spontaneous bleeding, especially in joints and muscles.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia